Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Numbers That Should Make Novavax Shareholders Smile


Novavax (NASDAQ: NVAX) missed Wall Street's revenue estimate in the fourth quarter of 2021. And it didn't matter. As proof, the vaccine maker's shares rose on Tuesday after Novavax's Q4 update following the market close on Monday.

But some things in the company's update really do matter. Here are two numbers that should especially make Novavax shareholders smile.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments